← Back

Consun Pharmaceutical Group

Consun Pharmaceutical Group Limited produces and sells pharmaceutical products in Mainland China through two segments: Consun Pharmaceutical and Yulin Pharmaceutical. Its portfolio includes uremic clearance granules for chronic renal failure, Yishen Huashi particles for proteinuria, and traditional Chinese medicine for diabetic kidney disease. It also offers contrast agents such as Gadopentetate Dimeglumine and Iopamidol injections, along with various other medicines for renal, gynecological, and other conditions. Founded in 1997, the company is headquartered in Guangzhou, China.

Country
Price · split & dividend adjusted
News & notes moving 1681.HK